Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 |
| Revenues | 0.3 | 0.0 | 0.0 |
| Cost of goods sold | 0.2 | 0.0 | 0.0 |
| Gross profit | 0.1 | 0.0 | 0.0 |
| Gross margin | 28.7% | | |
| Research and development | 9.5 | 5.0 | 5.1 |
| General and administrative | 10.0 | 4.4 | 3.3 |
| EBIT | -19.4 | -9.4 | -8.4 |
| EBIT margin | -7404.9% | | |
| Pre-tax income | -19.2 | -7.8 | -8.3 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | | |
| Net income | -19.2 | -7.8 | -8.3 |
| Net margin | -7342.2% | | |
| |
| Diluted EPS | | ($1.33) | ($8.78) |
| Shares outstanding (diluted) | | 5.9 | 0.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|